0032 265 09 20  

SARS-CoV-2 Rapid Antigen Test Nasal

Supplier Roche Diagnostics · Catalog number: 9901-NCOV-03G

86 USD

25 Tests/Kit

The SARS-CoV-2 Rapid Antigen Test is a lateral fl ow rapid chromatographic immunoassay for the qualitative detection of nucleocapsid antigen to SARS-CoV-2 present in human nasal samples. This test is intended for use as an aid in detection of SARS-CoV-2 infection in individuals suspected of COVID-19 with clinical symptoms onset within 5 days. Results are for the identification of SARS-CoV-2 nucleocapsid antigen. Antigen is generally detectable in human nasal swab samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co- infection with other viruses. The agent detected may not be the definite cause of disease. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The SARS-CoV-2 Rapid Antigen Test is intended for use in laboratory or POC settings by healthcare professionals, or self-collection under the supervision of a healthcare worke

  • Additional information:
    • Test type: Qualitative
    • Sample type: Nasal swab
    • Target antigen: Nucleocapsid (N)
    • Time to result: 15 minutes (Readout window 15 - 30 minutes)
    • Stability (test, opened pouch): 1 hour once the test has been opened
  • Storage and shipping:Storage temperature 2-30°C / 36 - 86°F

want a datasheet ?

want A Quote ?